FMP
Qualigen Therapeutics, Inc.
QLGN
NASDAQ
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
3.06 USD
0 (0%)
Historical Prices
From:
To:
Date
Open
Low
High
Close
Volume
Change
Change %
2025-03-14 10:36:00
3.05
3.04
3.05
3.04
1.51k
-
-
2025-03-14 13:24:00
3.07
3.07
3.07
3.07
0
0.03
0.99
2025-03-14 14:53:00
3.11
3.07
3.11
3.11
4.25k
0.04
1.3
2025-03-14 15:00:00
3.07
3.07
3.07
3.07
0
-0.04
-1.29
2025-03-14 15:12:00
3.11
3.11
3.11
3.11
2
0.04
1.19
2025-03-14 15:49:00
3.07
3.07
3.07
3.07
0
-0.04
-1.18
2025-03-14 15:59:00
3.06
3.06
3.06
3.06
411
-0.01
-0.33
